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INTRODUCTION 
Drug default is the failure of a patient to comply 
fully with medication regimens and is a major unsolved prob-
lem confronting health care providers today. Drug default 
~--------------
is also known as medication noncompliance. 
Jenkins (1) was one of the first to report on patient 
noncompliance. Although his study was somewhat limited in 
scope, Jenkins revealed that the average patient takes onl;i 
about 50 percent of the doses prescribed. The funny rumor 
that the grass outside the tuberculosis sanitarium dies of 
aminosalicylic acid toxicity may be well founded, for studies 
have shown that 50 to 90 percent of tuberculosis patients 
fail to comply with their regimens as prescribed by their 
physician (2-6). Malahy (7) in a study at Ohio State Uni-
versity found that of 40 patients receiving a total of 143 
different medications, only 10 percent were takj.ng their drugs 
as presc.ri.bed. Feinstein (8) pointed out that only 50 perce!:lt 
of children given oral prophylaxis for rheumatic fever were 
in compliance with their drug regimens. Si.milarly in one 
study (9) with instructions to take oral penicillin for 10 
days for documented streptococcal infections in children, 
82 percent discontinued their medication by the ninth day. 
Benstead a.nd Theobald (lO) and Bonnar and Goldberg (11) in 
- -,_-,--- -:;:::-- -----7----
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separate studies demonstrated that one out of three pregnant 
women fail to take iron preparations as directed. Caron and 
Roth ( 12) and Roth and Berger ( 13) have reported noncompli-
ance with antacid therapy for duodenal ulcers, while in a 
Veterans Administration study of drug treatment for hyper-
tension (14), 50 percent of patients were found to be non-
compli.ant. 
A number of studies have examined the unreliability of 
psychiatric patients in self administration of their medica-
tions. Parkes, et al., (15) found a drug default rate of 
44 percent whereas Wilcox ( 16) reported one of 48 percent. 
Kaebling and Larson (17) cited Gelber's study on released 
mental patients in which 40 percent did not adhere to the 
prescribed regimen, and Tybring and Kusuda' s study where 46 
percent released from Mendota State Hospital in Wisconsin 
discontinued their medications without their physicians' 
knowledge. Lynn (18) reported that only 43 percent of 133 
patients referred to him had taken their medications as 
instructed. 
The li.kelihood of drug default is g;reatest on an out-
patient basis since there is a lesser degree of supervision. 
However, although less prevalent, noncompliance can also be 
a problem in hospitalized patients. The practice of some 
patients, particularly those treated for psychiatric dis-
orders, to "cheek" their drugs is well recognized. Forrest, 
et2:l., (19) stated that spot checks as well as systemic 
-------- -=--=-=-==_c__ -
-----
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test:ing of hospital populations showed that from 5 to 15 
percent of the patients in well staffed hospitals success-
fully "cheek" their medications. In an outpatient clinic, 
the patient must be relied upon to take his medications 
correctly while the hospitalized patient is relieved from 
this responsibility. Drug distribution and drug administra-
tion is performed for the patient by the pharmacist, the 
p ys1c1an and the nurse. Thus 1 t J.s not Iog1cal to expeet 
patients to graduate from total dependence while hospitalized 
to eomplete independence immediately upon discharge from an 
institutional setting. 
Failure to take medications correctly can severely 
influence the effectiveness of. therapy, which in turn can 
lead to relapse and hospi.taliza tion ( 20) . Both results are 
undesirable; the former is a loss to society and the latter 
is a major -factor in spiraling costs of medical care (21,22). 
Major Factors Contributing to Drug D~fauH. 
The most important elements responsible for patient non-
compliance are: 
1. Failure to comprehend the importance of therapy 
duration (21,23). As with hypertension, diabetes, arthritis 
and other disease states, many mental disorders are chronic 
in nature. Continuing preventJve treatment may be essential 
to maintain a state of clJnical remission (22). Therefore, 
special effort should be made to impress upon the patient 
the importance of continuing treatment without interruption. 
4 
2. Poor understanding of i.nstructions (23, 24-27). 
Herman (28) stated that outpatients are unable to interpret 
directions such as B.I.D., T.I.D., Q,_!_.D. and empha.sized the 
necessity for pharmacists to assume the responsibility of 
scheduling doses. Utilizing a pharmacist rather than the 
patient to make decisions related to dosing schedules may be 
a more relaistic approach. Latiolais and Berry (23) and 
Sharpe (29) concluded from their studies that the frequency 
of medication errors decreased as clarity of instructions 
increased. However, emotional or mental problems of psychi-
atric patients may make it difficult for them to understand 
instructions. 
3. Multiple drug therapy and frequency of administra-
t•ion. Studies (1,7,25,30-32) have confirmed that the greater 
the number of drugs and/or the frequency of administration, 
the higher the risk of drug default. Polypharmacy or drug 
cocktails (the presence of more than one therapeutic ingre-. 
dient in a single dosage form) may help noncompli.ant patients 
to adhere to drug regimens by reducing the actual number of 
tablets and/or capsules taken at one time. However, poly-
pharmacy should only be considered once the optimal dosages 
of the individual drugs have been determined. Further, since 
many antipsychotic agents and tricyclic antidepressants can be 
admini.stered as a single daily dose rather than as divided 
doses (22,33-36), patient compliance can be improved by 
decrea.sing the frequency of administration of these drugs. 
--- ---- ----- -
--------
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4. Occurrence of side effects. Adverse effects .or side 
effects of medications can discourage compli.ance especially 
when they are unexpected (1,23,26,37). Marshall (38) noted 
that development of impotence to be a major reason for male 
patients to discontinue their antipsychotic treatment. Pur-
ther, tardive dyskinesia, a late-appearing neurological syn-
drome associated with antipsychotic drugs may be a deterrent 
~----------------
factor in patient compliance. Conversely, patient awareness 
of minor adverse effects such as dryness of mouth or gastro-
intestinal upset may help to prevent the development of fear 
in the patient (26). In the Wilcox study (16), the failure 
rate was not appreciably influenced by the presence of side 
effects. Single daily dosing of many psychotherapeutic agents 
at bedtime can be utilized to promote a better night's sleep 
and minimize the adverse effects during the day time . 
. 5. Forgetfulness. The literature is replete with 
studies implicating forgetfulness as an important factor in 
patient drug default (1,21,23,24,26,39). Geriatric patients 
pose a particular problem because of lapses in memory. 
6. Illness. Blackwell (27) pointed out that the schizo-
phrenic patients lack insight into the fact that they are 
sick and may discontinue their medications even though they 
are needed. Similarly, Hussar (36) anticipated a higher in-
cidence of drug default because of the nature of the patient's 
illness. Lati.olais and Berry (23) reported that overdosage 
is the most frequent type of drug misuse i.n psychiatric 
6 
paU.ents, because therapy will sometimes eliminate sympto-
mat.ic manifestations of the patient's illness, thus rendering 
him more prone to overdose himself. F.inally, there are the 
paranoid pa"tients who fear that medications may harm them (27). 
Measuring Patient Compliance 
Measures to study the drug default pattern can be clas-
Subjective Methods. Patie.nts are interviewed to evaluate 
the extent to which they adhere to the drug regimen. The 
patient interview has been used either alone or in combination 
with objective methods (8, 9,40,41-). Simple interrogation is 
n.ot ideal for eliciting such information since many patients 
lli.ight hesitate to admit to their physician that they deviated 
from his recommendation. Studies (11,40,42) have shown that 
the patient interview was inconsistent when compared with 
objective methods. Furthermore, some patients have the 
tendency to deny taking certain medications when they actually 
have. Chelton and Whisnant. (43) showed that 6 percent of· 
38 patients who have taken tranquilizers according to plasma 
determination denied taking them. 
Objective Methods. The objective methods are as follows: 
1. Detection of drug metabolite(s) in excretions 
or tablet markers in urine. Bonnar and Goldberg (11) used a 
stool test for elemental iron to verify cooperation of preg-
uant women in taking oral iron preparations. Urinalysis has 
been applied to several patient populations taking penicillin 
-
E 
li 
11 
li 
II 
li 
" I 
I 
I 
~ 
f. 
- ------- -------------- --- --------=-==-=~'--'- ---
7 
(9,44,45), antituberculosis drugs (3,4,25,37,36,47), and 
psychotropic drugs (16,19). Joyce (48) used phenol red wh::.le 
the Veterans Administration study (14) of drug treatment for 
hyper-cension and Porter ( 32) used riboflavine as a tablet 
marker to measure patient compliance. These detection methods 
have the folloWing disadvantages: 
a. If qualitative in nature, they cannot 
differentiate between underdosing and overdosing 
(24). 
b. They are applicable only when subjeets 
are taking one drug since multiple drug therapy 
might result in drug interference with analytical 
tests. Maddock (5) noted a 10 percent false posi-
tive test for amino salicylic acid in a study 
involving 425 urine samples from pat.ients known 
not to have taken amino salicylie acid. Joyce (48) 
in her study with phenol red as a tablet marker 
found that only 38 percent of the 108 urine 
samples which should have contained the marker 
gave positive readings. 
c. For excretion tests to be representative 
of the patient's usual drug consumption, multiple 
specimens should be collected (6), which is eostly 
and may be impractical. 
2. Unit count. This objective method allows for 
comparing the number of doses consumed by a patient with the 
8 
actual number of doses that should have been consumed accord-
ing to the physician's direction over a given period of 
time. This technique has been utilized in several studies 
(1,8,9,25,27,37,42,49). The disadvantages of unit count are: 
a. Patients may remove the medication from 
the container to create a good impression but 
ingest none of it (1). However, in case of over-
dosage such a problem does not exist. That is, 
once a patient has taken too many, it may be impos-
sible for this person to replace the pills to 
create a good impression. Roth, et al., (49) 
have shown that there is no certainty that what 
has left the bottle has been consumed by the 
patient. On the other hand, Moulding (6) stated 
that more aceurate :i.nformation can be obtained 
by making surprise visits to the patient's home or 
place of work to perform the unit count. On this 
basis, Linkewich, et_al., (50) and Irvin (51) 
used the unannounced unit count. 
b. Problems of noncompliance due to con-
sumption of contents in erratic manner are hard 
to identify (24). However, this may be eliminated 
with the unannounced unit count. Though Berman 
and Werner (9) found the results of unit count to 
be inconsistent with urine testing data in 29 per-
cent of 17 instances, urine tests may not be the 
9 
ideal method in measuring patient compliance as 
discussed previously. In Maddock's study (5), 
6 percent of 50 patients classified as coopera-
tive according to urine tests obtained less than 
60 percent of their prescribed drugs. 
Improving Patient Compliance 
between those patients who adhere welJ, from those who adhere 
poorly (12), health professionals have focused on compliance 
devices and patient counseling techniques to facilitate com-
· pliance. Moulding used a "pill calendar'' (52) and a "pill 
calendar dispenser" (53) to maintain and improve compliance. 
In 1970, Moulding (6) refined his pill calendar dispenser by 
including a radioactive material and photographic film to 
record the regularity with which medication packets are 
removed. Liberman (54), Arkwright (55), and Fris and Rosen-
crance (56) designed patient calendar sheets. Liberman and 
Swartz (57) ut.ilized visual and mechanic aids for a particular 
illiterate patient. Drug manufacturers have been using the 
pill dispenser concept to facilitate patient compliance for 
oral contraceptives and steroids such as Medrol Dosepak 
and Aristo-Pak. Linkewich, et al., (50) and Irvin (51) used 
unit dose prepacking as devices to facilitate compliance and 
minimize patient errors. Irvin, Gipson, and Catania (58) 
reported on the use of the Daily Medication Package, a 
10 
modification of (Medi-Dose),a to improve patient compliance. 
In their study, six subjects with a history of noncompliance 
or suspicion of same were referred to the investigators from 
the San Joaquin County outpatient mental health clinic. In 
four of the subjects there was an immediate and sustained 
improvement whereas in the remaining two subjects a gradual 
improvement was noticed. Gipson, et al., (59), Demetrol, et 
al. , ( 60), and Catania, et al. , . ( 61) further documented the 
utility of the Daily Medication Package to enhance compliance 
by psychiatric outpatients. 
As stated previously, poor understanding of instructions 
and failure to comprehend the importance of therapy are two 
of the major problems that contribute to drug default. Pos-
· sibly these problems may be resolved if the pharmacist 
directly counsels the patient as part of the dispensing 
function. Linkewich, et al., (50) found that imparting the 
information along with other procedures such as unit dose 
packaged tablets, increased compliance significantly. Mad-
den ( 39) not only showed tha,t counseling reduced misuse of 
drugs to a great extent, but more importantly demonstrated 
the phannacist's ability to convey to the patient the impor-
tance of continuing drug therapy as prescribed. Colcher and 
Bass (45) found that oral therapy with adequate parental 
counseling is as effective as intramuscular injection of 
aSupplied by Medi-Dose, Inc. , Sellerville, Pennsyl vani.a. 
-
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penicillin in the treatment of streptococcal pharyngitis. 
Furthermore, eounseling can minimize fear from unknown 
adverse effects. On the other hand, Latiolais and Berry (23) 
and Malahy (7) did not notice that intensive training produced 
a lesser n~~ber of medication errors. 
Very few studies have been reported comparing the effects 
of counseling and the unit dose packaging upon compliance. 
·E'urther, no studies have been reported on the effects of 
counseling and unit dose packaging upon compliance in ambu-
latory psychiatric patients. The present investigation was 
undertaken t-0-(-i~} -eval-ua'te-'lihe,-e~-:fec-t-i:veness--of--t-he -Med-ica~--
tion Reminder Record, a type of patient calendar sheet, with 
c·ounseling as a means of improving compliance with medication 
regimens in an ambulatory psychiatric patient population; and 
(ii) contrast the effects of the Daily Medication Package with 
counseling and the Medication Reminder Record for arnbulatory 
psychiatric patients. 
-
c 
METHODOLOGY 
Patient Population 
The study was performed during the period from November 
1977 through March 1978. Forty-two patients were referred 
to the investigator by private psychiatrists in the Stockton 
metropolitan area. Twe.nty-five patients met the following 
criteria set by the investigator: 
1. Presence of noncompliance or concern by the 
psychiatrist of possible noncompliance; 
2. Patient informed consent to participate in 
study (Appendix A); 
3. Local, stable residence within Stockton city 
limits; and 
4. Living in community (not in residential care 
facilities, i.e., board-and-care homes). 
The status of the 25 referred patients who met the 
selection criteria and were invited to participate are listed 
in Table I. Of the 14 patients who did not complete the 
study, only five patients dropped out of the investigation· 
due to personal objection to the study methodology. Two of 
the 11 patients who completed the study were randomly selected 
to be omitted from the analysis to provide an equal number of 
patients in all cells of a randomized block-3 design. 
12 
'rABLE I 
STA'l'US OF PATIENTS ACCEPTED INTO THE STUDY 
Number of 
Patients Status During Study 
l. Hospitalized during third month. 
3 Objected to the use of the Daily Medication 
1 
1 
Package. One patient ob,je;::ted to packaging 
not being child r'esistant and two patients 
objected because of disability resulting · 
from rheumatoid arthritis and stroke. 
Changed physician d~ring the first month. 
Physician temporarily discontinued all 
medications. 
13 
2 
.2 
4 
Objected to frequenc.y of unannounced visits. 
Moved without notifying the investigator. 
Personal resons (not divulged to the investi-
gator). 
. 11 Completed the entire 3 month study . 
-
"' 
l ; 
~ 
f! 
I 
ir 
! 
I 
I' 
I' 
! 
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Table II shows the demographic makeup of the nine 
patients used in this study. The population was predomi-
nantly female (2:1), with a mean age of 48.9 and an average 
of nine years education. The majority of the patients were 
of a low income level or were Medi-Cal (Medicaid) partici-
pants., Most of the patients were Caucasians, however 22.2 
percent were Chicanos and 11.1 percent were Blacks. 
The patient's psychiatric diagnosis is shown in Table III 
where 33.3 percent of the patients were being treated for 
schizophrenia, 22.2 percent for depression, ll.l percent for 
alcoholic psychosis, and 11.1 percent for mental retardation. 
Design 
Patients were randomly assigned to one of three groups, 
each of which received three different treatments, for a ran-
domized block-3 study (Figure 1). Each letter variable name 
( C, DMP, CS-)---represen-t,s-a-test- treatment-. --Each -c-olumn rep-re~ 
sents a single test patient (i.e., each patient receives all 
treatments but in different sequences). Each row represents 
a run in time (i.e., each run contains all treatments). 'l'he 
advantage of such a design is the elimination of patient to 
patient variance and reduction of bias in setting up Analysis 
of Variance CANOVA) experiments with only a limited number 
of patients. 
Patients received their medications at the pharmacy of 
their choice and for the purpose of this study, the pre-
scriptions were filled with a 28-day supply of medications 
Patient's 
Initials ·Sex Age 
S.M. F .49 
J.G. F 73 
M.S. F 31 
E.L. F 53 
M.B. F 40 
c.c. F 56 
C.H. 1\l 51 
c.o. M 40 
J.C. M 47 
=•="'~' .·.---c-=~:-=- --'='- ~-~· ~ ... -.-. --__ -,-c:.c=c·· 
TABLE II 
PATIENT'S DEMOGRAPHIC STATUS 
Years of 
Education Economic Status 
2 Medi-'Cal 
3 Medi-Cal 
6 Medi-Cal 
13 Medi-Cal 
12 Low Income 
8 Low Income 
9 Medi-Cal 
15 Medi-Cal & 
Disability 
13 Veteran 
Disability 
Race 
Chicano 
Chicano 
Caucasian 
Caucasian 
Caucasian 
Caucasian 
Caucasian 
Black 
Caucasian 
',111.1 :1:1 ltniL!Irl 1-ll.t:llll.l_''l:._l: :1 
>-' 
"~ 
I 
II: 1::1:: ' 
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TABLE III 
PATIENT'S PSYCHIATRIC DIAGNOSIS 
---------
- ---
-~~----~-~----- ----
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-
~28d 
c DMP cs 
DMP cs c 
cs c DMP 
-
-
C = Control 
D~W = Daily Medication Package 
CS = Counseling 
Figure 1. Randomized Block-3 Design 
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for each treatment. 
Control 
All patients in control treatment (C) obtained their 
medications in prescription vials and thepharmacist was 
instructed to read to the patient only those instructions 
requested by the physician to appear on the label. The 
control treatment data provided baseline compliance iriforma..:. 
tion for each patient. 
Daily Medication Package 
Prescriptions were repacked in Daily Medication Package 
(DMP), a unit dose packaging system, by the investigator. 
The instructions for the use of the package were explained 
to the patient. The Daily Medication Package system used 
in this study was Irvin's modification of (Medi-Dose).a 
See Figure 2. The usual prescription label was incorporated 
into the package. Each day's regimen was sealed into a 
single card with indications as to the date, day of the week, 
and time of the day~that each dose should be taken. The 
reverse side of each card showed the name of the medication, 
strength, prescription number, the names of the physician and 
pharmacy, along with any auxiliary labels. The four-week 
supply of the patient's repackaged medications was placed in 
chronological order in appropriate containers. The usual 
aSupplied by Medi-Dose, Inc., Sellerville, Pennsylvania 
-
c 
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For: John Doe Wodr.osday, Jar.u•ry 19. \9i7 
Physician: MaryWhite Mellarill Holdol rDyaz•d•l 
50m2 I 2mg · }---~~~~~~~~~~~~~~-
!-, _:_~~~~~~~~~~-f-~~~~---,fi.,!-,-, Oi'TAM-i- .. ~ 7-l!<ll ,, •. 7-80 '''P· •• ,.1 -~~ , ... -- .. , .. · -... , ....... , 
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L-----~ ~ ~ N ~ 
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®00~ 
006J~ 
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Figure 2. The Daily Medication Package 
~ 
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prescription label information was placed on each container 
for each of the patient's prescriptions. 
Counseling 
In the counseling phase (CS), the medications were dis-
pensed in prescription vials in a manner identical to the 
control phase. However, the investigator spent as much time 
as needed with each patient to reinforce, clarify and supple-
ment instructions so that the patient understood the physi-
cian' s instructions. To provide this degree of understanding, 
the investigator made certain that the patient was aware of 
the following points: 
1. 
2. 
3. 
4. 
Name and strength of medication 
Intended therapeutic use 
Time and frequency of administration 
The number of dosage units to be administered at 
each dosing interval and maximum daily dose for 
prn (if needed) medications 
5. Duration of therapy 
' 6. Side effects and auxiliary instructions 
7. Need to avoid certain other drugs or food, if any. 
Counseling was tailored to meet individual patient needs. 
Patients with impaired or limited mental acuity were given 
instructions on a level more easily understood. Counseling 
was with both verbal and written instructions, since the 
former alone might be forgotten especially if the patient is 
mentally or emotionally disturbed, and the latter by itself 
c 
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may be inadequate if the patient is illiterate, a foreign-
speaking American or with poor eye sight. All counseling 
was done by the investigator in the privacy of the patient's 
home. For foreign speaking patients, a bilingual social 
worker helped the experimenter during counseling sessions. 
Furt.her, the directions on all forms .were both in English 
and the patient's native language. 
-
c 
I .,-------~------------.c__--------~---
Written Instructions 
As part of the counseling phase of the experimental 
method, written instructions included a Medication Reminder 
Record (MRR), a type of patient calendar sheet, and Patient 
Package Inserts (PPI). The Medication Reminder Record con-
sisted of two sections (Appendix B). The left half included 
the medication name, directions and purpose of use, and the 
time(s) the medications were to be taken. The right half, the 
punch card section, included the date, the day of the week 
and perforated circles to be punched out as doses were taken. 
The rows as well as the columns were separated by perforated 
lines so that the Medicatiq,n Remin.der Record could be folded 
for the convenience of the patient. 
The Medication Reminder Record was designed and used to 
augment the counseling phase and to help (i) explain to the 
patient how to take hisjher medications; (ii) the patient 
remember the details of administration as stated by the 
investigator; and (iii) the patient to monitor his/her own 
medication administration. 
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The purpose of the Patient Package Inserts was to: 
1. help the patient better understand hisjher medi-
cations; 
2. emphasize the importance of following the schedule; 
3. suggest ways to deal with side effects and when to 
contact the physician or the pharmacist; and, 
4. remind the patient of possible drugfdrug interaction 
and drug/food interaction. 
For maximum effectiveness; counseling was not limited to 
psychotropic drugs but was extended to all medications taken 
by the patient. Further, for the purpose of this study, 
Patient Package Inserts, using the format of Sax, et al., 
(62), were incorporated into the counseling process. Patient 
Package Inserts were prepared and used for the following cate-
gories of therapeutic agents: 
L Phenothiazines (Appendix C) 
2. · •rricyclic amines and thioxanthenes (Appendix D) 
3. Benzodiazepenes (Appendix E) 
4. Hydantoi_ns (Appendix F) 
5. Hypnotics (Appendix G) 
6. Diuretics (Appendix H) 
7. Antihistamines (Appendix I) 
8. Cardiac glycosides (Appendix ,T) 
9. Hypotensive drugs (Appendix K} 
10. Phenobarbital used for epi.lepsy (Appendix L) 
These Patient Package Inserts were devloped by the investigator 
-
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and reviewed by the referring psychiatrists prior to using 
them in this study. 
Past medical history, present medical illness, medica-
tion profile, periodic lab tests evaluation, therapy monitor-
ing, and patient response were all part o:f an arsenal which 
the investigator used in counseling patients. The medica-
l Jl.!.------ct"i'-o::cn=:o;ac-dm-,-;;i;-n-:~:oc· s.-:~t=r-a-;;t-;:i;-;:o,--n~s=c"h:::e:::d1u~l--=e=w=a=s=a:::d:-:J:-:·u=-s=-'t=-e=d::<:<:we>:i:-t--:h=c=-l---:.i~n-.i1c-:a:-l--::-e::-:f=:f-i_-____ _ 
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cJ.ency in mind and minimal interference with the daily acti-
vities o:f the patient. During 'the four-week consultation 
period, a telephone number was available to the patients for 
consultation with the investigator at all times. 
~easure of Compliance 
The unit count was utilized as the measurement technique 
in the study. All unit counts were made during home visits 
by the investigator. To minimize the possibility of a patient 
accurately anticipating the unit count, all counts were 
unannounced and were made at different times of the day. The 
unexpected visits were done twice a week. No statistical 
randomnization of the day and time of home visits was at~ 
tempted, for home visits could be made only when the patient's 
and investigator's schedules were compatible. When the 
patient was not available at the time of the unannounced 
visit, the investigator repeatedly returned until contact 
was made. 
In this study, noncompliance was defined as (i) a drug 
prescribed by a physician and not taken by the patient, 
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( ii) a drug taken in incorrect doses, (iii) a drug taken at 
the wrong time, or (iv) a drug that has been discontinued 
by the physician but is still being administered by the 
patient. Therefore, a fully compliant patient is one who 
takes 100 percent of all prescribed doses at the right time 
(± 2 hours). During the study, the physicians informed the 
investigator of any addition or deletion of medication and/or 
any change ~n dose ~n order to make proper count. 
Compliance was measured by dividing the number of tab-
lets or capsules actually taken by the theoretical number of 
tablets or capsules which should have been taken by a fully 
compliant patient times 100. An over-compliant patient will 
score greater than 100 percent whereas a score of less than 
100 percent will denote under-compliance. Since the method 
depends totally on an accurate unit count, the investigator 
(i) emphasized to the patient the importance of taking the 
medications from appropriate containers (prescription vials 
or Daily Medication Package); and (ii) retained all old 
prescription containers to prevent the patient from having 
more than one source of medication. 
Assessment of Counseling 
At each visit, the investigator would ask the patient 
if he would recall the use, dosing, time and frequency of 
administration of a randomly selected patient medication. 
If the patient failed to answer correctly any of the above 
questions, the counseli.ng instructions on all medications 
~-------------- --------"-- - ---- ---------- - - --- -
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were repeated. In addition, if noncompliance was noted, an 
attempt was made by the investigator to correct it through 
additional counseling. 
I 
I 
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RESULTS 
Prescriptions 
The mean number of regularly administered prescriptions 
(prn prescriptions excluded) was 4.0 for the control phase, 
4.5 for the Daily Medication Package phase, and 4.7 :-'or the 
counseling phase whereas the mean-prescription number per 
patient was 4.4. See Table IV. Although the unit count for 
the prn medications was checked at each visit, the data was 
not included in the analysis. 
Analysis. 
The number of unannounced visits was the study unit for 
the purpose of data analysis, except for comparing the unit 
cour1t and the punch card system in measuring compliance 
(Table IX). Because the data on the punch card system was 
collected at the end of the counseling phase and not at each 
home visit, the number of patients was utilized as the study 
unit rather than the number of unannounced visits. 
The mean departure from 100 percent compliance for 
each treatment phase in the randomized block-3 design is 
presented in Figure 3. The proportion of patients achieving 
100 percent compliance, as illustrated in Figure 4, was 
greater with the Daily Medication Package (65.3 percent) and 
counseling ( 61.1 percent) tha.n with control ( 15.3 percent). 
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TABLE IV 
AVERAGE NUMBER OF PRESCRIP'l'IONS PER PATIENT IN EACH TlmATMENT 
Mean Number of Prescriptions Mean Number of 
Patient's Control Daily Medication Counseling Prescriptions of 
Initials Period Package Period Period all Treatments 
S.M. 5.375 6.875 6.750 6.333 
J.G. 3.500 3.250 5.625 4.125 
M.S. 2.250 3.625 3.125 3.000 
E.L. 6.000 6.000 5.125 5.708 
M.B. 4.750 4.375 4.750 4.625 
c.c. 4.500 5.000 7.000 5.500 
C.H. 3.000 3.000 3.000 3.000 
c.o. 4.625 4.000 4.3'75 4.333 
J.C. 2.000 4.000 2.625 2.875 
Total 36.000 40.125 42.375 39.499 
x 4.0 4.5 4.7 4.4 
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Statistical analysis (Table V) revealed the difference be-
tween the Daily Medication Package, counseling and control 
to be very highly significant (P < 0. 001). Further analysis 
(Table VI-VIII) showed that (i) the Daily Medication Package 
differed significantly from control (~ < 0.001); (ii) coun-
. seling. differed significantly from control (P < 0. 001); but 
(ii;i.) _the Daily Medication Package did not significantly 
differ from counseling(~> 0.25). 
Figures 5 through 13 were obtained by the use of the 
computer "Burroughs 6700," and the graphic program "R(Q024ll4 )" 
at the University of the Pacific, Stockton, California. These 
figures show a graphical presentation of patient departure 
from full compliance (100 percent compliance) at.the unan-
nounced visits in each treatment phase. Improvement in com-
plian.ce appears to be more uniform with the Daily Medication 
Package than with counseling. However, upon statistical 
analysis, the difference was not significant (~ > 0.05). 
See variance ratio column in Table VIII. 
Figures 14 and 15 confirm that the greater the number of 
drugs and/or the frequency of administration, the higher the 
rate of noncompliance. Patients receiving three prescriptions 
or less daily had a compliance rate of 64.3 percent as com-
pared to 43.1 percent for those receiving more than three 
prescriptions daily. In the related data, patients taking 
five doses or less a day, 6-10 doses a day, and more than 
10 doses a day showed a compliance rate of 89.6, 45.0, and 
28.4 pe.rcent respectively. 
-
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TABLE V 
RANDOMIZED BLOCK-3 ANALYSIS 
Degrees of Sums of 
Term Freedom Squares Mean Square f 
Between 
Treatments 2 7523.48 3761.74 26.03 
Between 
Patients 8 25839.71 3229.96 22.35 
Residual 
Error 205 29627.21 = 144.523 
Total Error 215 62990.39 
I 
p 
(observed) 
I 
<. 0. 001 
(0. 001 
s = 12.o227 
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TABLE VI 
COMPARISON OF THE DAILY MEDICATION PACKAGE VERSUS 'fONTROL 
-- - -----
Control Daily Medication 
Package 
F 
Mean Departure from 100 N Mean Departure from 100 (Obs•~rved 
Percent Compliance, %~ Percent Compliance, % + P) 
standard error. standard error. -
19.52 + 2.38 72 6.32 + 1.46 46 07 
((0 001) 
. 
' ' 
! 
' ' 
---
Variance 
Ratio 
(Observed ~) 
2.65 
((0.001) 
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TABLE VII 
COMPARISON OF COUNSELING VERSUS CONTROL 
. 
Control Counseling 
N I Mean Departure from 100 F N Mean Departure from 100 (Observed Percent Compliance, % ~ Percent Compliance, % + 
standard error. standard error. ~) 
. 
72 19.52 + 2.38 72 7.82 + 1.75 21 :. 04 
((( I, 001) 
I 
I 
I 
' 
' 
' 
I ' 
"' .. ,-~·-···-·. 
Variance 
Ratio 
(Observed ~) 
1.85 
((0.01) 
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TABLE VIII 
COMPARISON OF COUNSELING VERSUS THE DAILY MEDICATION PACKAGE 
. 
. 
·-
-
Daily Medication Package Counseling 
F 
N Mean Departure from 100 N Mean Departure from 100 (Obs erved 
. Percent Compliance, % + Percent Compliance, % + ~) 
standard error. standard error. 
I 
I 
72 ! 6.32 + 1.46 72 7. 82 + l. 75 I o.f49 (>O. 5) 
' 
' 
' 
' 
. 
' 
' 
I 
·: ' ' I 
Variance 
Ratio 
(Observed P) 
1.432. 
(>0.05) 
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Although the unannounced unit count was utilized as 
the measurement technique in this study, the investigator 
decided to compare the data of the punch card system of the 
Medication Reminder Record with that of the unit count in 
measuring patient compliance. Compliance determined by the 
punch card system was not significantly different than com-
pliance determined by the unit count (P > 0.5). See Table IX. 
Tables X and XI present a time and cost factor compari-
son between the Daily Medication Package and counseling. 
The average cost of counseling by the pharmacist per 28-day 
prescription period was $5.83. The average additional 
prescription cost per 28 days for the Daily Medication 
Package varied from $5.63 to $9.04 depending upon whether 
the packaging was performed by a technician or a registered 
pharmacist. 
The type of consultation and number of telephone calls 
received by the investigator during the counseling phase are 
shown in Table XII. The mean number of telephone calls was 
1.3 per patient per 28 days of consultation. Eight out of the 
12 telephone calls were directly related to clarification of 
specific points previously discussed in consultation, two 
telephone calls to notify the investigator of drug misuse, 
and two telephone calls to bring to the attention of the 
investigator an addition or a deletion of a medication 
ordered by the psychiatrist. 
---------------- -- ~--- --i-~~~~~---~-----------~. 
TABLE IX 
COMPARISON OF THE UNIT COUNT AND THE PUNCH CARD lnYSTEM 
OF THE MEDICATION REMINDER RECORD IN MEASURING COM~LIANCE 
'';IJJ_I iLl ~IIllrllf! .. l.ll:lllil!.r.L.; 
""'" -l . !! 
ji 
I, 
I iirl. 
-------------------.1..-------~~-·•--'~'~"c'--~· 
Patient's 
Initials 
S.M. 
J.G. 
M.S. 
E.L. 
M.B. 
c.c. 
C.H. 
c.o. 
J.C. 
Total 
-
X = 
TABLE X 
COMPARISON OF TIME FACTOR BETWEEN THE DAILY MEDICA'):'ION 
PACKAGE AND COUNSELING 
Daily Medication Package ·r- Counseling 
Time/28 days, 
Rx1 N 
Time/28 days, 
Rx, N Doses/day, N min min 
6.875 10 240 1looo 89 
8looo 3.250 12 150 64 
41ooo 3.625 6.167 98 55 
6.000 13.714 190 6 000 44 
4.375 13.428 295 6 000 107 
5.000 6.000 100 8 000 71 
3.000 6.000 150 3 000 28 
4.000 5.000 92 8.000 68 
4.000 6.000 170 3 .000 40 
---
531. 00~ 40.125 78.309 1485 565 
37.0 minjRx; x = 0.7 min/dose x b 10.7 minjRx 
x ~ 62.8 min/patient 
w: ,: r I l1!111.1jll- TIJ:IIj!H ·! 
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Labor 
Material 
Total 
TABLE XI 
COMPARISON OF COST FACTOR BETWEEN THE DAILY MEDICATION 
PACKAGE AND COUNSELING 
Cost per Prescription for 28 day suptly 
Counseling* Daily Medication Packa :, .. e 
L----. 
Packaging done by Packaging done by 
Pharm. Tech. R. Ph. 
$1.95 $3.39** $6.80*** 
$3.88 $2.24 . $2.24 
---
$5.83 $5.63 $9.04 
-
' 
* Initial cost of $121.00 for the die of 
** Based upon projected wage for hospital 
*** Based upon projected wage for hopsital 
the punch card syst•~m not included. 
pharmacy technicianf of $5.50/hour. 
pharmacists of $11.90/hour. 
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TABLE XII 
NUMBER AND TYPE OF CONSULTATIONS RECEIVED BY THE INVESTIGA~)R BY TELEPHONE 
Number of Telephone Calls I Type of Consu~tation 
8 
2 
2 
To clarify specific points breviously discussed 
in consultation I 
To notify the investigator bf physician's 
order change (voluntarily dtne by the patients) 
To notify the investigator ' f personal drug 
misuse I 
:: , 1 ~ 1 i r: 1 1mrn1u --r11J11rn -r-·i ::1 
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DISCUSSION 
An important part of medical care for the ambulatory 
psychiatric patient is self administration of medications over 
a long period of time. It is known, however, that patients 
vary in the regularity with which.they take their medica-
tions. Failure to identify nonreliable patients has led 
health professionals to focus on devices and counseling 
techniques to facilitate complianee. The absence of studies 
reporting the effect of counseling ai1d packaging upon 
psychiatric outpatients prompted this first study using am-
bulatory psychiatric patients in a community environment. 
Ambulatory patients with a history of noncompliance or 
suspicion of same were referred to the investigator by 
private psychiatrists for a randomized block-3 design study. 
Each patient received control, the Daily Medication Package, 
and counseling treatments in different sequences, each treat-
ment lasting 28 days. 
The results show that the use of the Medication Reminder 
Record with counseling and the Daily Medication Paekage are 
equally effective in improving patient compliance. Since 
some of the major factors contributing to patient noncompli-
ance are failure to comprehend the importance of duration of 
therapy and poor understanding of instructions, counseling 
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greatly assisted in i.mproving compliance in these areas. 
~-
Forgetfulness, which is also one of the important elements 
responsible for patient noncompliance, has been minimized 
with the use of the Daily Medication Package and the Medica-
-
"" tion Reminder Record used in counseling. When the investi·-
·gator triedto correlate the consequences of side effects 
upon compliance, three patients admitted the presence of 
some side effects but in no way did it discourage them from 
taking their medications. This finding is in agreement with 
Wilcox, et al., (16) that compliance is not appreciably 
influenced by side effects. 
Upon assessment of the Daily Reminder Record and the 
Daily Medication Package, two patients indicated some diffi'-
culty in punching out the perforated circles of the punch 
card system of the Medication Reminder Record, whereas only 
one .Patient complained of the inconvenience with the use of 
the Daily Medication Package. When patients were individually 
queried, two-thirds of them favored the Daily Medication 
Package over the Medication Reminder Record. 
Patients have the right to be informed about matters 
related to their personal health care. Therefore, it is 
evident that someone must spend some time with the patients 
to explain how to take the medications properly. The pharma-
cist, because of his educational background and his profes-
sional obligation, is the best person to counsel the patients. 
The pharmacist should be warm, sincere, and understanding in 
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order to establish a friendly relRtionship wi.th the patient 
to engender trust and confidence and ultimately encourage 
compliance. Since compliance is a complex phenomena that 
requires understanding patient behavior, pharmacists involved 
in counseling will need additional training in psychology to 
- imp:rove the effectiveness of their performance in patient 
counseling. Patient's use of the telephone in the present 
the assurance and rapport that developed between the patients 
and the investigator. Further, these patients expressed con-
fidence in the investigator's activities and advice. 
The average consultation time per patient was 62.8 min-
utes which is 2.5 times more than the uncomplicated discharge 
consultation (25 minutes), and 1 to 1.5 times more than the 
complicated one (40-60 minutes) reported by Cole, et al., 
(26). They conducted their study in a short term general 
hospital and defined a complicated discharge case as one that 
requires consultation with the physician andjor identifica-
tion of medications already being taken by the patient. Some 
of the factors responsible for the difference between the 
two studies may be due to: 
l. mental and emotional conditions of the patient; 
2. number of prescriptions administered daily; 
3. difference in educational level of the patient; and 
4. difference in counseling ap~roach. 
The average additional prescription cost per 28 days 
for counseling ($5.83) and for the Daily Medication Package 
-
R-
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($5.63 to $9.04) is above and beyond the c.ost of conven-
tional prescription medication. Yet this increased commit-
ment of expense for compliance is insignificant in comparison 
to the expense for patient rehospitalization as a result of 
noncompliance (36). One potential economical advantage of 
·c.ounseling over the Daily Medication Package is the possi-
bility that after a number of consultation periods, counsel-
ing time and counseling cost will be reduced. The actual 
number of consultations necessary will, of course, vary from 
patient to patient. 
Three of the nine patients in the study volunteered to 
-----
the investigator, on more than one occasion, that talking 
with the investigator actually did help them psychologically. 
This is in agreement with Ivey's statement (63) that psychi-
atric patients need psychological support and the pharmacist 
can contribute in this area by listening, communicating, 
and advising the patient. All patients expressed apprecia-
tion that the investigator was providing information which 
they desired but were reluctant to ask their psychiatrist. 
Of clinical significance, both epileptic patients were 
unaware that alcohol might bring about a seizure. In fact, 
although both patients were weekend drinkers, they were 
counseled to abstain completely from alcoholic beverages. 
The investigator does not know for sure if these patients 
eliminated the alcohol from their s.ocial pattern as a result 
of this advice. 
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The results on Table IX indi.cate that the punch card 
system of the Medication Reminder Record is as effective as 
the unit count in measuring compliance. However, the punch 
card system, or any other similar device, should be further 
tested to verify its reliability as an independent measure-
ment technique. In addition, the punch card system of the 
Medication Reminder Record should be further evaluated and 
compared with counseling as an aid to compliance. 
At the beginning of the study, most of the psychiatrists 
reluctantly referred their patients to the investigator. As 
a matter of fact, some of them opposed the idea of the inves-
tigator being involved in counseling their patients in any way 
and refused to refer patients into the study. However, once 
pos:i.tive patient response was received by the psychiatrists, 
the number of referrals greatly increased. At the end of 
the.study, the psychiatrists expressed their gratitude for 
the counseling services offered to their patients by the 
investigator. In a similar manner, the patients were quite 
appreciative. of the results achieved. Further, several 
patients expressed disappointment at the termination of 
the experiment. These patients had hoped that the experiment 
would become a full fledged compliance service for them. 
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SUMMARY AND CONCLUSIONS 
This report determined the rate of drug compliance for 
ambulatory psychiatric patien_ts. Patients utilizing the 
control, i.e., conventional prescription medication methods, 
had a compliance rate of 15.3 percent. The provision of 
counseling with the Medication Reminder Record increased the 
compliance rate to 61.1 percent (P < 0.001). The. use of the 
Daily Medication Package resulted in a compliance rate of 
65.3 percent (P < 0.001). 
The combination of the Medication Reminder Record with 
counseling was statistically as effective as the Daily Medi-
cation Package in improving patient compliance.. Based upon 
the data presented, patients who are noncompliant because of 
poor understanding of instructions, failure to understand 
the importance of duration of therapy, or fear of becoming 
drug dependent will apparently benefit best from counseling. 
On the other hand, patients who are noncompliant because of 
transient emotional or mental disturbances, or forgetfulness 
will be able to comply effectively with the Daily Medication 
Package, the Medication Reminder Record or any similar 
device. However, one should admit that compliance is a 
complex phenomena and there may not be a 100 percent effec--
tive approach. 
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The pharmacist is in a unique position to monitor ambu-
latory patient compliance since he has more frequent contact 
with the patient than any other health care provider. Fur-
ther, he has at his disposal the patient medication profile, 
a ·relatively dependable way of monitoring drug therapy and 
compliance. In addition, his/her educational background in 
pharmacology, toxicology, pharmacokinetics, and supportive 
pharmaceutical sciences is superior to that of any of the 
other health care professional. Finally basect upon the 
results of this study, a community based compliance service 
for ambulatory psychiatric patients may become a valuable 
component of comprehensive clinical pharmacy services. 
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APPENDIX A 
Patient Informed Consent Form 
.CONSENT.FOR PARTICIPATION IN DRUG COMPLIANCE.STUDY 
I understand that the observation l.nvolving medication 
taking provided by Albert T. Gazzar is for the sole purpose 
of a study to test new ways to help people comply with their 
drug regimens. 
It is my understanding that the medication pills will 
be counted every few days and that the drug package may not 
be child resistant and I authorize its use. 
I understand that I am free to ask any questions I may 
have about the study and that I may drop out at any time. 
Printed Name: 
Signature: 
Date: 
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APPENDIX B 
The Medication Reminder Record 
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APPENDIX C 
Phenothiazines 
PATIENT PACKAGE INSERT 
This medication has been selected specifically for your 
need. The medication will be of greatest benefit to you if 
you carefully follow the direction on the Medication Reminder 
Record. 
DO NOT STOP taking your medication even though you are 
feeling well except upon the advice of your doctor. 
Because tliis medication may cause DROWSINESS, CAUTION 
SHOULD BE EXERCISED when operating dangerous machinery such 
as automobiles. 
DO NOT TAKE ALCOHOLIC BEVERAGES or other depressant 
drugs such as sleeping aids except Under direct supervision 
of your doctor. 
If you should develop unusual shaking, stiffness; rest-
lessness or jerks while on this medication, contact your 
doctor since in most cases they may be quickly and effectively 
controlled. 
This medication may cause sometimes dry mouth which can 
be alleviated by chewing a SUGARLESS gum. 
BLURRING OF VISION 
with this medication but 
period of time. 
at the beginning of therapy occurs 
generally disappears within a short 
Occasionally constipation or 
may be caused by this medication. 
arise, notify your doctor as they 
trolled. 
difficulty in urination 
Should these conditions 
may be effectively con-
Since this medication may cause faintness or light-
headedness, it is suggested that you sj_ t or lie down if you 
begin to feel dizzy. 
Avoid prolonged exposure to direct sunlight while 
taking this medication. 
65 
If you develop SORE THROAT while on this medication, 
contact me or your doctor. 
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If you feel you need more. information on this medica-
tion, contact me. 
This is a partial list of the side effects of this 
drug; if you experience any other adverr;e effect, contact 
· me or your doctor. 
---- -------- ----- -·. 
APPENDIX D 
Tricyclic amines and thioxanthenes 
PATIENT PACKAGE INSERT 
This medication has been selected specifically for your 
need. The medication will be of greatest benefit to you if 
you carefully follow the directions on the Medication 
Reminder Record. 
DO NOT STOP TAKING your medications even though you are 
feeling well except upon the advice of your doctor. 
Because this medication may cause DROWSINESS, CAUTION 
SHOULD BE EXERCISED when operating dangerous machinery such 
as automobiles. ' 
DO NOT TAKE ALCOHOLIC BEVERAGES or other depressant 
drugs such as sleeping aids except under direct supervisl.on 
of your doctor. 
This medication may cause sometimes unpleasant taste or 
dry mouth which can be alleviated by chewing a SUGARLESS gum. 
Occasionally constipation 
be caused by this medication. 
notify your doctor as they may 
or difficulty in urination may 
Should these conditions arise, 
be effectively controlled. 
Since this medication may cause faintness or light-
headedness, it is suggested that you sit or lie down if you 
begin to feel dizzy. · 
This medication has GRADUAL ONSET AND EFFECTS WILL NOT 
BE EVIDENT IMMEDIATELY. 
If you develop SORE THROAT while on this medication, 
contact me or your doctor. 
This medication.may cause excessive sweat which can be 
wiped off. 
If you feel you need more information on this medication, 
contact me. 
This is a partial list of the side effects of this drug; 
if you experience any other adverse effect, contact me or 
your doctor. 
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APPENDIX E 
Benzodiazepenes 
PATIENT PACKAGE INSERT 
~------------~Thi~ea~&a~-i~\~~n-s~~a~pecifical~y for 
your need. The medication will be of greacest benefit to 
you if you carefully follow the directions on the Medica-
tion Reminder Record. 
Because -this medication may cause DROWSINESS, CAUTION 
SHOULD BE EXERCISED when operating dangerous machinery such 
as automobiles. 
DO NOT TAKE alcoholic beverages or other depressant 
drugs such as sleeping aids except under direct supervision 
of your doctor. · 
If you feel you need more information on this medica-
tion, contact me. 
This is a partial list of the side effects of this 
drug~ if you experience any other adverse effect, contact 
me or your doctor. 
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APPENDIX F 
Hydantoins 
PATIENT PACKAGE INSERT 
Th:is medication has been selected specifically for your 
need. The medication will be of greatest benefit to you if 
-
c 
you carefully follow the directions on the__M_~a.:tinn_Remindar__ 
Record. 
Take your medication .DAILY ON A REGULAR BASIS and do not 
stop taking it except upon the advice of your doctor. 
This medication may cause sometimes nausea and vomiting 
which can be alleviated by taking the medication with food. 
If you develop SORE THROAT while on this medication, 
contact me or your doctor. 
Occasionally a skin rash may develop with this medica-
tion. Should this condition arise, notify your doctor. 
If you develop dizziness, slurred speech or mental con-
fusion while on this medication, contact your doctor since 
in most cases they may be controlled. 
Occasionally this medication may cause gum enlargement 
which may be reduced by good oral hygiene such as gum massage 
and frequent brushing. 
If you feel you need more information on this medica-
tion, contact me. 
This is a partial list of the side effects of this 
drug; if you experience any other adverse effect, contact me 
or your doctor. 
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APPENDIX G 
Hypnotics 
PATIENT PACKAGE INSERT 
This medication has been selected specifically for your 
need. The medication will be of greatest benefit to you 
ll-------:if-:y~u-e1trei'urly fo.Llow the c:hrecfions on the Medication 
Reminder Record. 
I 
I' II [ 
DO NOT TAKE ALCOHOLIC BEVERAGES or other sleeping aids 
except under direct supervision of your doctor. 
If you feel you need more information on this medica~ 
tion, contact me. 
This .is a partial list of the side effects of this drug; 
if you experience any other adverse effect, contact me or 
your doctor. 
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APPENDIX H 
Diuretics 
PATIENT PACKAGE INSERT 
This medication has been selected specifically for your 
need. The medi · 1 be~-f-g-----~a..t-~~t-9-e-n-e-f-4.--t-t-0-------j~a j_fc-. ------
you carefully follow the directions on the Medication Reminder 
Record. 
Take your medication DAILY ON A REGULAR BASIS and do 
not stop taking it except upon the advice or your doctor. 
If you develop MUSCLE WEAKNESS while on thj.s medication, 
contact me. 
This medication may cause sometimes nausea an.d vomiting 
which caR be alleviated by taking the medication with food. 
If you feel you need more information on thi.s medi.ea-
tion, contact me. 
This is a partial list of the side effects af this drug; 
if you experience any other adverse effect, contact me or 
your doctor. 
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APPENDIX I 
Antihistamines 
PATIENT PACKAGE INSERT 
This medication has been selected specifically for your 
need. The medication will be of greatest ·benefit to ou if 
you care u y o ow t e directions on the Medication 
Reminder Record. 
Because this medication may cause DROWSINESS, CAUTION 
SHOULD BE EXERCISED when operating dangerous machinery such 
as automobiles. 
DO NOT TAKE ALCOHOLIC BEVERAGES or other depressant 
drugs such as sleeping aids except under direct supervision 
of your doctor. 
If you feel you need more information on this medica-
tion, contact me. 
This is a partial list of the side effects of this drug; 
if you experience any other adverse effect, contact me or 
your doctor. 
-
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APPENDIX J 
Cardiac glycosides 
PATIENT PACKAGE INSERT 
This medication has been selected specifically for 
your need. The medication will be of g:reate$t~nei-'it-_r.o,--~~~~­
you if you carefully follow the directions on the Medication 
Reminder Record. 
Take your medication DAILY ON A REGULAR BASIS and do 
not stop taking it except upon the advice of your doctor. 
If you develop LOSS OF APPETITE, NAUSEA, VOMITING, 
DIARRHEA, VISUAL DISTURBANCES (blurred vision, yellow vision) 
while on this medication, contact me or your doctor. 
If you feel you need more information on this medica-
tion, contact me. 
This is a partial list of the side effects of this drug; 
if you experience any other adverse effect, contact me or 
your doctor. 
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APPENDIX K 
-
Hypotensive drugs ~ 
PATIENT PACKAGE INSERT 
This medication has been selecte · sp.ru::.ific.a_ll y fo.:r---.>U..>U-!'0"--c------
nee The medication will be of greatest benefit to you if 
you carefully follow the directions on the Medication 
Reminder Record. 
Take your medication DAILY ON A REGULAR BASIS and do 
not stop taking it except upon the advice of your doctor. 
Since. this medication may cause FAINTNESS OR LIGHT 
HEADEDNESS, it is suggested that you sit or lie down if you 
begin to feel dizzy. 
If you feel you need more information on this medica-
tion, contact me. 
This is a parU.al list of the side effects of this 
medication; if you experience any other adverse effect, 
contact me or your doctor. 
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APPENDIX L 
Phenobarbital used for epilepsy 
PATIENT PACKAGE INSERT 
This medication has been selected specifically for your 
need. The medication will be of greatest benefit to you if 
1----~y·au---ea-re~tt±-}J>~fo-:t-low----tire-di:rectil:m s on t ne M.edi cat 1.on 
Reminder Record. 
Take your-medication DAILY ON A REGULAR BASIS and do 
not stop taking it except upon the advice of your doctor. 
Because this medication may cause DROWSINESS, CAUTION 
SHOULD BE EXERCISED when operating dangerous machinery such 
as automobiles. 
DO NOT TAKE ALCOHOLIC BEVERAGES or other depressant 
drugs such as sleeping aids except under direct supervision 
of your doctor. 
If you feel you need more information on this medica-
tion, contact me. 
This- is a partial list of the side effects of this 
drug; if you experience any other adverse effect, contact 
me or your doctor. 
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